See more : Commonwealth Bank of Australia (CBA.SW) Income Statement Analysis – Financial Results
Complete financial analysis of KMS Medisurgi Limited (KMSMEDI.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of KMS Medisurgi Limited, a leading company in the Medical – Specialties industry within the Healthcare sector.
- Quanergy Systems, Inc. (QNGY) Income Statement Analysis – Financial Results
- Orient Securities Company Limited (600958.SS) Income Statement Analysis – Financial Results
- Oconee Financial Corporation (OSBK) Income Statement Analysis – Financial Results
- JinFu Technology Co., Ltd. (003018.SZ) Income Statement Analysis – Financial Results
- Kvasir Education Ltd (KVSR.TA) Income Statement Analysis – Financial Results
KMS Medisurgi Limited (KMSMEDI.BO)
Industry: Medical - Specialties
Sector: Healthcare
About KMS Medisurgi Limited
KMS Medisurgi Ltd. engages in the manufacture of medical and surgical equipment. It focuses on the marketing and distribution of medical devices, surgical disposables, hemostat, surgery equipment, radiology, oncology, diagnostic equipment, cardiology, critical care, urology, research, and other scientific equipment. The company was founded by Gaurang Prataprai Kanakia on March 25, 1999 and is headquartered in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 138.85M | 110.27M | 103.17M | 75.10M | 103.44M |
| Cost of Revenue | 122.34M | 94.62M | 91.27M | 69.22M | 95.50M |
| Gross Profit | 16.51M | 15.65M | 11.90M | 5.88M | 7.94M |
| Gross Profit Ratio | 11.89% | 14.19% | 11.54% | 7.83% | 7.67% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 11.19M | 8.52M | 9.02M | 4.06M | 5.10M |
| Other Expenses | 0.00 | -242.00K | -150.00K | -77.58K | -271.58K |
| Operating Expenses | 11.19M | 8.76M | 9.17M | 4.14M | 5.37M |
| Cost & Expenses | 133.53M | 103.38M | 100.44M | 73.36M | 100.87M |
| Interest Income | 0.00 | 84.00K | 133.00K | 665.57K | 262.16K |
| Interest Expense | 208.00K | 279.00K | 390.00K | 332.49K | 710.24K |
| Depreciation & Amortization | 2.51M | 3.18M | 2.91M | 3.31M | 4.05M |
| EBITDA | 9.08M | 10.06M | 5.64M | 6.02M | 6.59M |
| EBITDA Ratio | 5.64% | 9.13% | 5.47% | 6.73% | 6.40% |
| Operating Income | 5.32M | 6.89M | 2.73M | 1.74M | 2.57M |
| Operating Income Ratio | 3.83% | 6.25% | 2.65% | 2.32% | 2.48% |
| Total Other Income/Expenses | 723.00K | -304.00K | 122.00K | 631.89K | -742.27K |
| Income Before Tax | 6.04M | 6.59M | 2.85M | 2.37M | 1.82M |
| Income Before Tax Ratio | 4.35% | 5.97% | 2.76% | 3.16% | 1.76% |
| Income Tax Expense | 1.51M | 856.00K | 700.00K | 1.14M | 700.00K |
| Net Income | 4.54M | 5.73M | 2.15M | 1.23M | 1.12M |
| Net Income Ratio | 3.27% | 5.20% | 2.09% | 1.64% | 1.09% |
| EPS | 1.38 | 1.74 | 0.65 | 0.37 | 0.34 |
| EPS Diluted | 1.38 | 1.74 | 0.65 | 0.37 | 0.34 |
| Weighted Avg Shares Out | 3.30M | 3.30M | 3.30M | 3.30M | 3.30M |
| Weighted Avg Shares Out (Dil) | 3.30M | 3.30M | 3.30M | 3.30M | 3.30M |
Source: https://incomestatements.info
Category: Stock Reports